Eric Johnston, Cantor Fitzgerald chief equity and macro strategist, joins 'Money Movers' to discuss Johnston's thesis for ...
We recently compiled a list of the 14 AI Stocks Making Waves on Wall Street. In this article, we are going to take a look at ...
Cantor Fitzgerald assumed coverage of Zevra Therapeutics (ZVRA) with an Overweight rating and $25 price target Zevra is a rare disease, ...
The Securities and Exchange Commission (SEC) on Thursday charged Cantor Fitzgerald L.P., a global financial services firm ...
In a report released yesterday, Ross Osborn from Cantor Fitzgerald reiterated a Buy rating on Avita Medical (RCEL – Research Report), with a ...
Fintel reports that on January 6, 2025, Cantor Fitzgerald initiated coverage of aTyr Pharma (NasdaqCM:ATYR) with a Overweight ...
Cantor Equity Partners I, Inc. (Nasdaq: CEPO) (the "Company") announced today that it priced its initial public offering ...
Cantor Fitzgerald has recently initiated Aquestive Therapeutics Inc (AQST) stock to Overweight rating, as announced on December 17, 2024, according to Finviz. Earlier, on May 10, 2024, Leerink ...
On Tuesday, Vincerx Pharma Inc (VINC) stock saw a modest uptick, ending the day at $0.21 which represents no change from the prior close of of $0.21. The stock opened at $0.21 and touched a low of ...
Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating ...
Cantor Fitzgerald reiterated their overweight rating on shares of TeraWulf (NASDAQ:WULF – Free Report) in a research report released on Monday,Benzinga reports. Cantor Fitzgerald currently has a ...